|
Gerhard Koenig brings more than 15 years of research and development experience to EnVivo Pharmaceuticals, with an important focus on neurodegeneration and Alzheimer’s Disease. As Chief Scientific Officer, Gerhard is focusing on the daily scientific and operational management of the company. He has co-authored major scientific publications, patents and reviews of new research findings in prestigious journals. Previously, Gerhard spent 10 years at Bayer Corporation in West Haven, CT and at Bayer AG, Germany in various functions, including Director of the Dementia Research Department at Bayer AG, Germany. In his last function, he was responsible for the pre-clinical dementia research pipeline and that work resulted in the introduction of several compounds into development. Gerhard received his M.S. and his Ph.D. degree in Molecular and Cellular Biology, graduating Suma Cum Laude from the University of Heidelberg, Germany. | 